Breast Cancer
Phase II Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women who have Hormone Receptor-positive Advanced Breast Cancer Previously Treated with an Aromatase Inhibitor
Trial ID: 06030
Contact: Carolyn Cox
Phone: (281)863-6641
Learn More about this trial.
go back | new search